Rare disease drug development is a rapidly expanding field with growing pressure for getting more orphan drug approved to treat rare diseases. There is a vast consensus among patients, health care bodies, governments etc. to expedite drug development in this field. Some wonderful numbers that attest to growing interest in rare diseases and orphan drugs […]

Read More →

Thailand FDA periodically releases list of of institutional review boards (IRBs) / ethics committees (ECs) that it recognizes for acceptance of clinical trials. Under Thailand regulatory system, approved ethics committees serve as the main point of approvals for initiating clinical trials in the country. This has been explained in our previous articles (see Part I and Part II), […]

Read More →

Sri Lanka was one of the first countries to embrace the concept of clinical trial registration.  The SLCTR was recognized as a Primary Registry of the Registry Network of the WHO‐ICTRP in March 2008, being the fourth Primary Registry to join the Network.   Why Sri Lanka? Sri Lanka is an emerging market for clinical trial […]

Read More →

New Zealand could be an interesting choice of region for national and international organisations seeking to pursue clinical research  and looking for most preferred destination in Asia-Pacific Region. New Zealand, a country named third most beautiful country in the world with stunning and diverse natural beauty, jagged mountains, is full of islands with one of Earth’s most […]

Read More →

Mexico is rapidly becoming a major player in the pharmaceutical and medical device industries. A recent report states that It’s the number one exporter of medical devices in Latin America and 8th in the world and also a leading exporter of pharmaceutical products in Latin America. Having diverse demographic profile gives enormous potential for the recruitment of patients on a […]

Read More →

Hong Kong has a impeccable history of international research with impressive track record of conducting global clinical trials. It has an outstanding healthcare system and indicated as one of the lowest infant mortality rates and the longest life expectancy in the world. Hong Kong is an emerging market for clinical trials. It is the world’s eighth largest […]

Read More →

Thailand is the second largest healthcare market in Southeast Asia after Indonesia making up roughly about 20% of the region’s expenditure. Thailand’s pharmaceutical market is the eight largest in the Asia Pacific region and considered as one of the largest and most developed in ASEAN. Why choose Thailand as your Generic Drug Market? Thailand’s Generic market presents […]

Read More →

Singapore is considered as the R&D pioneer in Asia with highly qualified clinicians, a solid and advanced infrastructure, cutting-edge technology, commitment by the government to become one of the preferred clinical research destinations worldwide. Singapore is central to the region (South East Asia) and hub of the life sciences industry, acting as a pacesetter to […]

Read More →

Japan is the world’s second-largest single-country pharmaceutical market, accounting for approximately 10 percent of global drug sales and expanding quickly. Top foreign pharmaceutical companies operating in Japan enjoy annual growth rates from 12 to 31 percent, rivaling the expansion observed in emerging markets. This growth spurt has been largely attributed to the Japanese government’s multi-year […]

Read More →

China has brought significant reforms in its regulatory system for pharmaceutical industry and clinical trials. In its continuous drive to improve the system, recently China’s Food and Drug Administration (CFDA) announced a major overhaul of its medical device regulations as well. To the current regulations, China has made significant changes. Summarily, 12 articles were newly […]

Read More →